Frazier Lifesciences Acquisition Accounts Payable

Frazier Lifesciences Acquisition (FLAC) currently reports a accounts payable of $940K as of September 2022. That compares with $45K in the prior-year period — up 1997.0% year over year. Use the charts on this page to explore Frazier Lifesciences Acquisition's accounts payable history and peer comparisons.

Frazier Lifesciences Acquisition's accounts payable increased from $45K to $940K — a 1997.0% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Frazier Lifesciences Acquisition reported $940K in accounts payable as of September 2022. That compares with $45K in the prior-year period — up 1997.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $940K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Frazier Lifesciences Acquisition, and consider following FLAC for alerts when major investors trade the stock.